Skip to main content

Table 1 Overview of patients with Pompe disease with a proven SARS-CoV-2 infection

From: Mild disease course of SARS-CoV-2 infections and mild side effects of vaccination in Pompe disease: a cohort description

Patient; Pompe type

Age

Gender

Age at diagnosis

Age at start ERT

Pompe disease severity

Recent immune modulation

BMI

FVC sitting/supine before infection

FVC reduction after infection

COVID disease duration (days)

Symptoms

Long-term symtoms

Chest X-ray

SARS-CoV-2 antibody titer

1. Classic infantile

8

F

4 months

4 months

Moderate. Responsive to ERT

No

20.7

67/no recent measurement

No

7

Cough, headache

No

n/a

n/a

2. Classic infantile

8

F

8 days

10 days

Moderate. Responsive to ERT

No

17.6

91/74

n/a

3

Fever, headache, ear pain

No

n/a

n/a

3. Classic infantile

11

F

3 days

8 days

Moderate. Responsive to ERT

No

20.3

86/87

n/a

2

Tiredness, sore throat

No

n/a

n/a

4. Classic infantile

16

F

6 days

16 days

Moderate. Wheelchair bound

No

22.3

56/no recent measurement

Yes; normalized after 1 month

7

Cough, stuffed nose, left-sided muscle weakness

Left-sided muscle weakness

n/a

n/a

5. Childhood

20

M

2 years; 4 months

9 years; 9 months

Mild

No

19.9

94/90

No

15

Sore throat, stuffed nose, general weakness, anosmia, loss of taste

No

n/a

n/a

6. Classic infantile

22

F

12 years; 3 months

No ERT

Mild

No

21.5

90/86

n/a

8

Fever, cough, anosmia, headache, stuffed nose

No

n/a

n/a

7. Classic infantile

22

M

20 days

4 months

Severe. Non-invasive ventilation, wheelchair bound

No

24.6

27/not possible

No

n/a

No symptoms

No

n/a

n/a

8. Childhood

22

M

3 years; 6 months

6 years

Mild

No

25.1

79/68

No

6

Cough, anosmia

Anosmia

n/a

n/a

9. Childhooda

29

F

15 years

23 years

Mild

No

30

125/115

No

10

Cough, stuffed nose, myalgia, headache, fatigue

Fatigue

Normal after recovery

n/a

10. Childhood

29

M

2 years

15 years

Mild

No

23

102/94

No

16

Cough, stuffed nose, anosmia, loss of taste

Anosmia

n/a

Positive 1,7 months after first symptoms

11. Late onset

40

F

24 years

26 years

Moderate. Use of nightly non-invasive ventilation

No

26

50/25

No

14

Fever, dyspnea, fatigue, myalgia, nausea, chest pain, anosmia, loss of taste

Fatigue, anosmia, chest pains, pain between shoulders, palpitations

n/a

Positive 4 months after first symptoms

12. Late onset

49

F

37 years

38 years

Mild

No

27

61/34

No

19

Cough, myalgia, fever, chest pain, sore throat, headache, diarrhoea

Fever, dyspnea during exercise, heart palpitations

Normal after recovery

n/a

13. Late onset

49

F

36 years

38 years

Moderate. Use of walking aid

No

27.9

82/50

Yes, asymptomatic, no new spirometry yet

7

Myalgia, nausea, bloated feeling

No

n/a

n/a

14. Late onset

60

M

56 years

Discontinued in 2018

Mild

No

27

83/78

No

9

Cough, fever, headache

No

n/a

n/a

15. Late onseta

62

F

59 years

59 years

Mild

No

28.1

82/64

No

n/a

No symptoms

No

n/a

n/a

  1. aTwo patients were infected after receiving their first dose of vaccination. Mild disease severity: classified as no use of ventilator or walking aid
  2. N/a not available